Page last updated: 2024-10-30

mesalamine and Osteomyelitis

mesalamine has been researched along with Osteomyelitis in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.

Research Excerpts

ExcerptRelevanceReference
"An 80-year-old man with Crohn's disease treated with mesalazine presented with collapse and tonic-clonic seizure."1.46Delayed diagnosis of central skull-base osteomyelitis with abscess: case report and learning points. ( Chawdhary, G; Corbridge, R; Hussain, S, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chawdhary, G1
Hussain, S1
Corbridge, R1

Other Studies

1 other study available for mesalamine and Osteomyelitis

ArticleYear
Delayed diagnosis of central skull-base osteomyelitis with abscess: case report and learning points.
    Annals of the Royal College of Surgeons of England, 2017, Volume: 99, Issue:1

    Topics: Abscess; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Delayed Diagnosi

2017